Collagen synthesis inhibitors, glucocorticoids, immunosuppressants, cytokine inhibitors, tyrosine kinase receptor inhibitors, endothelin antagonists, and anticoagulants are the most common clinically prescribed therapies for IPF patients. Here, NTRK1 is linked to idiopathic pulmonary fibrosis.